A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Clinical trial NCT06906380 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06906380
Sponsor: ARCE Therapeutics, Inc.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia, in Relapsed or Refractory MDS (Myelodysplastic Syndrome)

Start date: 2026-03-15
Primary completion: 2040-05-30
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.